Gabelli Funds’s Vigil Neuroscience VIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding VIGL
Gabelli Funds's VIGL Position: Q3 2025 in Review
Gabelli Funds sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 1,189,528 shares — an estimated $9.46M sold.
Gabelli Funds first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $9.46M in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.
- Gabelli Funds reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
- Gabelli Funds sold 1,189,528 Vigil Neuroscience shares in Q3 2025, an estimated $9.46M.
- Gabelli Funds first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
- Gabelli Funds's Vigil Neuroscience position peaked at $9.46M in Q2 2025.
- 2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.
Based on Gabelli Funds's 13F filing for Q3 2025, filed 12 Nov 2025.